MedPath

APO-BRIVARACETAM

APO-BRIVARACETAM

Approved
DIN Number

02538709

Drug Class

Human

Market Date

Sep 10, 2024

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02538709
AIG Number0157931004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX23 BRIVARACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

BRIVARACETAMActive
Strength: 75 MG
Monograph: BRIVARACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.